Likewise, striatal F-Dopa [217, 218], DAT [158, 218-223] and VMAT2 [218] uptake/binding values have been shown to diminish longitudinally in early-stage PD patients and atypical Parkinsonism, with the latter generally presenting with faster decline rates. The gene discussed is SLC18A2; the disease is Parkinson disease.